NCT05820061

Brief Summary

Diseases associated with upper gastrointestinal tract (UGIT) are common and associated with significant morbidity and mortality globally. Peptic ulcer disease, gastroesophageal reflux disease and cancers affect millions of people worldwide. Upper endoscopy used for various diagnostic and therapeutic utic indications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
800

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jan 2020

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

March 27, 2023

Completed
23 days until next milestone

First Posted

Study publicly available on registry

April 19, 2023

Completed
Last Updated

April 19, 2023

Status Verified

March 1, 2023

Enrollment Period

3 years

First QC Date

March 27, 2023

Last Update Submit

April 6, 2023

Conditions

All Patients With Upper GIT Symptoms and Underwent Upper Endoscopy

Outcome Measures

Primary Outcomes (1)

  • spectrum of distribution of endoscopic findings

    To assess endoscopic findings in patients presented with upper gastrointestinal symptoms

    2 years

Interventions

upper endoscopyDIAGNOSTIC_TEST

data will be collected from the enoscopy archive files in Department of Tropical Medicine and Gastroenterology,Sohag University Hospital

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may not qualify if:

  • Absolute Contraindications
  • Perforated bowel.
  • Peritonitis.
  • Toxic megacolon in an unstable patient. Relative Contraindications
  • Severe neutropenia.
  • Coagulopathy.
  • Severe thrombocytopenia or impaired platelet function.• Increased risk of perforation including connective tissue disorders, recent bowel surgery or bowel obstruction.
  • Aneurysm of the abdominal and iliac aorta

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Sohag University Hospital

Sohag, Egypt

Location

MeSH Terms

Interventions

Gastroscopy

Intervention Hierarchy (Ancestors)

Endoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor at Tropical Medicine and Gastroenterology department

Study Record Dates

First Submitted

March 27, 2023

First Posted

April 19, 2023

Study Start

January 1, 2020

Primary Completion

December 31, 2022

Study Completion

December 31, 2022

Last Updated

April 19, 2023

Record last verified: 2023-03

Locations

EG(1)